Low dose Canagliflozin effectively reduces hs-CRP and CR markers in diabetes Medha Baranwal22 Jun 2020 9:00 AM ISTDelhi: Canagliflozin 100mg is as good as canagliflozin 300mg in the reduction of hs-CRP and CR markers in patients with type 2 diabetes, according to...
Job related strenuous exercise may shorten longevity, finds new study Hina Zahid21 Jun 2020 6:45 PM ISTResearchers have found that strenuous exercise as an occupation reduces lifespan. The study has been published in the journal Palgrave...
Glenmark receives DGCI approval for launching Favipiravir in India Dr. Kamal Kant Kohli21 Jun 2020 6:14 PM ISTGlenmark Pharmaceuticals has received approvals from Drug Controller General of India to manufacture and market Favipiravir, an anti-viral drug, to...
Management of Pain in Sickle Cell Disease: ASH releases new guidelines Hina Zahid21 Jun 2020 5:15 PM ISTPain guideline is the latest in Society's evidence-based series of clinical practice guidelines for sickle cell disease aiming to improve and...
JB Chemicals brings BP Lowering Drug, Azelnidipine (DHP CCB) to Indian market under brand name Azovas Meghna A Singhania20 Jun 2020 12:45 PM ISTNew Delhi: Known for its Calcium Channel Blockers (CCB) range for the management of hypertension, JB Chemicals and Pharmaceuticals Ltd has brought yet...
Susceptibility to diabetes revealed as early as eight years of age: Study Dr. Kamal Kant Kohli20 Jun 2020 9:51 AM ISTDiabetes doesn't develop overnight.It develops for many years before diagnosis.Researchers have found in a new study that early signs of being more...
MMR vaccine may prevent septic inflammation associated with COVID-19 infection Dr. Kamal Kant Kohli19 Jun 2020 9:30 PM ISTThere is mounting evidence that live attenuated vaccines provide nonspecific protection against lethal infections unrelated to the target pathogen of...
Deprescribing BP medications does not disturb BP control in elderly: JAMA Medha Baranwal19 Jun 2020 8:38 PM ISTUK: A recent study published in the journal JAMA throws light on whether medication reduction in older patients can help achieve blood pressure (BP)...
Intranasal DHE safe and effective option for migraine, finds clinical Trial Medha Baranwal19 Jun 2020 8:29 PM ISTDelhi: Intranasal dihydroergotamine (DHE) that targets the upper nasal region is a well-tolerated and effective treatment for migraines,...
Simple blood test could one day diagnose motor neurone disease Hina Zahid19 Jun 2020 7:00 PM ISTScientists at the University of Sussex have identified a potential pattern within blood which signals the presence of motor neuron disease; a...
SGLT2 inhibitor Bexagliflozin reduces blood sugar, high BP and weight in diabetics Medha Baranwal19 Jun 2020 5:30 PM ISTDelhi: The investigational drug Bexagliflozin was found to be well-tolerated in high-risk diabetes patients in a phase 3 study. According to the...
Outpatient use of Azithromycin increases risk of CVD and non CVD death: JAMA Medha Baranwal19 Jun 2020 3:15 PM ISTUSA: Outpatient azithromycin use increases the risk of cardiovascular (CV) death and noncardiovascular death, according to a recent study in...
